These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 18334062)
1. HIV infection and the pancreas: risk factors and potential management guidelines. Manfredi R; Calza L Int J STD AIDS; 2008 Feb; 19(2):99-105. PubMed ID: 18334062 [TBL] [Abstract][Full Text] [Related]
2. A case-control study of HIV-associated pancreatic abnormalities during HAART era. Focus on emerging risk factors and specific management. Manfredi R; Calza L; Chiodo F Eur J Med Res; 2004 Dec; 9(12):537-44. PubMed ID: 15689299 [TBL] [Abstract][Full Text] [Related]
3. Study of prevalence, severity, and etiological factors associated with acute pancreatitis in patients infected with human immunodeficiency virus. Dutta SK; Ting CD; Lai LL Am J Gastroenterol; 1997 Nov; 92(11):2044-8. PubMed ID: 9362189 [TBL] [Abstract][Full Text] [Related]
4. Abnormalities of serum amylase and lipase in HIV-positive patients. Argiris A; Mathur-Wagh U; Wilets I; Mildvan D Am J Gastroenterol; 1999 May; 94(5):1248-52. PubMed ID: 10235202 [TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181 [TBL] [Abstract][Full Text] [Related]
6. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study. Smith CJ; Olsen CH; Mocroft A; Viard JP; Staszewski S; Panos G; Staub T; Blaxhult A; Vetter N; Lundgren JD AIDS; 2008 Jan; 22(1):47-56. PubMed ID: 18090391 [TBL] [Abstract][Full Text] [Related]
7. Pancreatitis associated with human immunodeficiency virus infection: a matched case-control study. Dowell SF; Holt EA; Murphy FK Tex Med; 1996 Sep; 92(9):44-9. PubMed ID: 8826775 [TBL] [Abstract][Full Text] [Related]
8. Gabexate mesilate and/or octreotide in human immunodeficiency virus-associated pancreatic abnormalities. Manfredi R; Calza L; Chiodo F Aliment Pharmacol Ther; 2002 Oct; 16(10):1791-4. PubMed ID: 12269972 [TBL] [Abstract][Full Text] [Related]
9. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients. Ortega KL; Vale DA; Magalhães MH J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. Smyth K; Affandi JS; McArthur JC; Bowtell-Harris C; Mijch AM; Watson K; Costello K; Woolley IJ; Price P; Wesselingh SL; Cherry CL HIV Med; 2007 Sep; 8(6):367-73. PubMed ID: 17661844 [TBL] [Abstract][Full Text] [Related]
11. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. Jaspan HB; Berrisford AE; Boulle AM Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556 [TBL] [Abstract][Full Text] [Related]
12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
13. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787 [TBL] [Abstract][Full Text] [Related]
14. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic]. Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753 [TBL] [Abstract][Full Text] [Related]
15. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114 [TBL] [Abstract][Full Text] [Related]
16. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study. Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U; Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519 [TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy in HIV. Yu A; Berbari E; Temesgen Z J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997 [TBL] [Abstract][Full Text] [Related]
18. Etiology of chronic diarrhea in antiretroviral-naive patients with HIV infection admitted to Norodom Sihanouk Hospital, Phnom Penh, Cambodia. Chhin S; Harwell JI; Bell JD; Rozycki G; Ellman T; Barnett JM; Ward H; Reinert SE; Pugatch D Clin Infect Dis; 2006 Oct; 43(7):925-32. PubMed ID: 16941378 [TBL] [Abstract][Full Text] [Related]
19. Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy. Lima VD; Gill VS; Yip B; Hogg RS; Montaner JS; Harrigan PR J Infect Dis; 2008 Jul; 198(1):51-8. PubMed ID: 18498238 [TBL] [Abstract][Full Text] [Related]